Ronald Gentile, MD

Ronald Gentile, MD is a  vitreoretinal surgeon with over 20 years of combined experience in diagnosing and treating retinal diseases. His expertise and specific research interests include diabetic eye disease, retinal vascular disorders, macular diseases, retinal detachments, endophthalmitis, ocular imaging and ocular trauma. The goal of his research includes not only to elucidate mechanisms of ocular diseases, but also to prevent blindness from a variety of retinal diseases. Advancing diagnostic capabilities and improving treatments, both medical and surgical, has been paramount to him. In addition to his many years of experience in clinical ophthalmic and surgical practice, he is an active principal investigator on federal and industry grants to study innovative retina diagnostics, non-contact imaging, and novel therapies.  He has ongoing collaborations with a number of laboratories and industry partners, nationally and internationally, and actively participate in cutting-edge medical research, developing new retinal treatments that not only prevent blindness, but also improve both the patient’s vision and their quality of life. Over his career, he has collaborated with other basic scientists and academic institution researchers. He is an active reviewer for many scientific ophthalmic journals and a member of the American Board of Ophthalmology, the American Society of Retina Specialists, the Macular Society, the New York Ophthalmological Society and a former president of the New York Academy of Medicine, Ophthalmology Section.  As a clinical professor, he is also actively involved in educating medical students, residents, clinical and research ophthalmologists in training and have made significant contributions to integrating research across all ophthalmic disciplines in their training curriculums. He is the president of Operation Restore Vision, a non-profit chapter of the International Surgical Mission Support and have successfully brought sight restoring surgery, teachings, and research to ophthalmologists in third world countries. These experiences have given him a strong foundation for translational application and invention of next generation pathophysiological concepts, surgical techniques, treatments, and diagnostic tests for a variety of blinding ocular diseases.